myelin

A molecular switch can turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), Mayo Clinic researchers have discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central… Read more

The same mechanism by which damaged peripheral nerves can regenerate after an injury could be activated in cells of the central nervous system – after a spinal cord injury, for instance, new research indicates. “An injury in the peripheral nervous system quickly triggers the activation of a fascinating repair process that allows the injured nerve… Read more

A novel imaging technique provides structural information about brain tissue that was previously difficult to access. Diattenuation Imaging (DI), developed by scientists at Forschungszentrum Jülich and the University of Groningen, enables researchers to distinguish regions with many thin nerve fibres from regions with few thick nerve fibres. With existing imaging methods, these tissue types cannot… Read more

People with multiple sclerosis who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug, a new study has found. The effect was particularly evident among MS patients who took beta interferon for more than three years. “This is a significant study. Although these… Read more

A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing. Researchers at Purdue University and the Indiana University School of Medicine found that acrolein, a molecule previously suspected as a metabolic waste product that accumulates in people with certain neurological disorders such… Read more